Related Experiment Video
Updated: Sep 3, 2026
08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
Xiaojing Zhang1, Jianbo Zhong2, Liming Wu2
1Department of Dermatology Hangzhou First People's Hospital Xiasha Campus, Hangzhou Rehabilitation Hospital Hangzhou China.
Clinical Case Reports
|September 2, 2026
Abstract:
Alopecia areata is an autoimmune disease with diverse clinical manifestations. This case report describes a patient with diffuse alopecia areata who responded well to oral abrocitinib, resulting in complete hair regrowth. The patient achieved complete recovery without any observed adverse effects.
Related Concept Videos
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...